Core Scientific shares traded lower Thursday (April 16, 2026) as the market focused on balance-sheet risk tied to its AI infrastructure expansion. The company recently expanded its bridge term loan by $500 million to $1.0 billion and drew the full amount, increasing near-term leverage and raising investor attention on refinancing risk and execution timelines for AI/HPC projects. (tradingview.com)

A fully drawn, short-dated secured facility can amplify equity volatility because it concentrates repayment and rollover risk into a relatively tight window. For CORZ, the funding is intended to speed high-density data-center development, but investors often discount the stock when financing costs and maturity walls become more visible—especially in companies still transitioning business models. (tipranks.com)

The leverage concern lands as Core Scientific continues shifting away from reliance on bitcoin mining toward AI/HPC colocation, where revenue conversion depends on delivering power, cooling, and space aligned with customer deployment schedules. The company has highlighted a large AI infrastructure contract pipeline tied to these buildouts, but the market is weighing that longer-duration upside against nearer-term funding and execution risks. (investing.com)

Key swing factors for the stock include any update on refinancing plans for the bridge debt, incremental announcements converting megawatts into contracted AI revenue, and broader crypto risk appetite that can spill over into miner-adjacent equities. Investors will also watch whether the company signals further asset sales or capital markets activity to support construction schedules and liquidity. (investing.com)